Evolent Health Inc
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Evolent Health, Inc. | |
| By: | /s/ John Johnson |
|---|---|
| Name: | John Johnson |
| Title: | Chief Financial Officer |
Dated: February 20, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Seth Blackley | Chief Executive Officer and Director | February 20, 2025 |
| Seth Blackley | (Principal Executive Officer) | |
| /s/ John Johnson | Chief Financial Officer | February 20, 2025 |
| John Johnson | (Principal Financial Officer) | |
| /s/ Aammaad Shams | Chief Accounting Officer | February 20, 2025 |
| Aammaad Shams | (Principal Accounting Officer) | |
| /s/ Toyin Ajayi | Director | February 20, 2025 |
| Toyin Ajayi, MD | ||
| /s/ Craig Barbarosh | Director | February 20, 2025 |
| Craig Barbarosh | ||
| /s/ Russell Glass | Director | February 20, 2025 |
| Russell Glass | ||
| /s/ Peter Grua | Director | February 20, 2025 |
| Peter Grua | ||
| /s/ Diane Holder | Director | February 20, 2025 |
| Diane Holder | ||
| /s/ Richard Jelinek | Director | February 20, 2025 |
| Richard Jelinek | ||
| /s/ Kim Keck | Director | February 20, 2025 |
| Kim Keck | ||
| /s/ Cheryl Scott | Director | February 20, 2025 |
| Cheryl Scott | ||
| /s/ Brendan Springstubb | Director | February 20, 2025 |
| Brendan Springstubb | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.